1) chelerythrine chloride
灯盏花素乙
1.
Effect of PKC inhibitor,chelerythrine chloride,on NO/cGMP signaling pathway in the spinal cord of rat with visceral inflammatory pain;
PKC抑制剂灯盏花素乙对内脏炎症痛大鼠脊髓NO/cGMP信号转导系统的影响
2) scutellarin
[,skjutə'lærin]
灯盏花乙素
1.
Study on metabolites of scutellarin in gastrointestinal tract by UPLC-MS/MS method;
UPLC-MS/MS联用法分析灯盏花乙素在胃肠道的代谢物
2.
Determination of Scutellarin in Breviscarpin Tablets by HPLC;
HPLC法测定灯盏花素片中灯盏花乙素的含量
3.
Effects of scutellarin on liver function after brain ischemia/reperfusion in rats;
灯盏花乙素对脑缺血再灌注损伤大鼠肝功能的影响(英文)
3) scutellarein
[skju:tə'lærin]
灯盏花乙素苷元
1.
Protection of scutellarein on cerebral ischemia in rats
灯盏花乙素苷元对实验性脑缺血的保护作用
2.
OBJECTIVE To establish a HPLC-ECD method for determining scutellarin in rat plasma and to study pharmacokinetics of scutellarein in rats.
目的研究大鼠灌胃给药灯盏花乙素苷元的药动学。
3.
Objective:To analyze the pharmacokinetics profiles of scutellarein in plasma of rats.
目的:比较灯盏花乙素苷元不同剂量给药的大鼠药动学。
4) breviscapine
灯盏花素
1.
The formula of breviscapine oral disintegrating tablets and its preparation;
灯盏花素口腔崩解片的制剂处方和制备工艺的研究
2.
Preparation of breviscapine proliposome by fluidized bed coating method;
流化床包衣法制备灯盏花素前体脂质体的研究
3.
Changes of high sensitivity C-reactive protein level after Breviscapine injection treatment in acute ischemic stroke patients and its mechanism;
灯盏花素治疗急性脑梗死对超敏C反应蛋白的影响及疗效机制
5) breviscapin
灯盏花素
1.
Preparation of breviscapin calcium alginate gel beads;
灯盏花素海藻酸钙凝胶小球的制备
2.
Effect of breviscapine on the oxygen free radicals in diabetic rats;
糖尿病大鼠氧自由基变化及灯盏花素对其的影响
3.
Ginaton and Breviscapin rescueing N-Methyl-N-nitrosourea-induced retinal deg eneration in SD rats;
金钠多、灯盏花素对N-甲基-N-亚硝脲诱导SD大鼠视网膜变性的保护作用
6) scutellarin
[,skjutə'lærin]
灯盏花素
1.
Preparation and the in vitro release characteristics of scutellarin sustained-release dropping pills;
灯盏花素缓释滴丸的制备及其体外释放特性的研究
2.
The study on initial burst release of Scutellarin Proliposome Capsules;
灯盏花素前体脂质体胶囊突释的评价方法
3.
Effects of borneol on the pharmacokinetics of scutellarin in rats;
冰片对灯盏花素在大鼠体内药动学的影响
补充资料:灯盏花素
分子式:暂无
分子量:暂无
CAS号:暂无
性质:暂无
制备方法:暂无
用途:血管扩张药,用于缺乏性脑血管疾病。
分子量:暂无
CAS号:暂无
性质:暂无
制备方法:暂无
用途:血管扩张药,用于缺乏性脑血管疾病。
说明:补充资料仅用于学习参考,请勿用于其它任何用途。
参考词条